Molecular blockade of VEGFR2 in human epithelial ovarian carcinoma cells

Silencing or Fueling Metastasis with VEGF Inhibitors: Antiangiogenesis Revisited

(2009) Sonja Loges et al.   CANCER CELL

Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

(2009) John M.L. Ebos et al.   CANCER CELL

Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis

(2009) Marta Pàez-Ribes et al.   CANCER CELL

Current Status on Biologic Therapies in the Treatment of Epithelial Ovarian Cancer

(2009) Ernest S. Han et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

The promises and pitfalls of RNA-interference-based therapeutics

(2009) Daniela Castanotto et al.   NATURE

Neuropilin-1 Upholds Dedifferentiation and Propagation Phenotypes of Renal Cell Carcinoma Cells by Activating Akt and Sonic Hedgehog Axes

(2008) Ying Cao et al.   CANCER RESEARCH

Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation

(2008) Xiaoyun Liao et al.   CARCINOGENESIS

Maintenance Treatment with Bevacizumab Prolongs Survival in an In vivo Ovarian Cancer Model

(2008) S. Mabuchi et al.   CLINICAL CANCER RESEARCH

Molecular and pathological signatures of epithelial–mesenchymal transitions at the cancer invasion front

(2008) Olivier Wever et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis

(2008) Ifat Sher et al.   INTERNATIONAL JOURNAL OF CANCER

Functional significance of VEGFR-2 on ovarian cancer cells

(2008) Whitney A. Spannuth et al.   INTERNATIONAL JOURNAL OF CANCER

Dual-targeted Contrast Agent for US Assessment of Tumor Angiogenesis in Vivo

(2008) Jürgen K. Willmann et al.   RADIOLOGY

Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia

(2007) Agustin A. Garcia et al.   JOURNAL OF CLINICAL ONCOLOGY